Compare GDOT & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GDOT | INMD |
|---|---|---|
| Founded | 1999 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 650.5M | 842.0M |
| IPO Year | 2010 | 2018 |
| Metric | GDOT | INMD |
|---|---|---|
| Price | $10.51 | $13.46 |
| Analyst Decision | Sell | Hold |
| Analyst Count | 2 | 6 |
| Target Price | $11.00 | ★ $16.75 |
| AVG Volume (30 Days) | 452.8K | ★ 863.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.33 | N/A |
| Revenue | ★ $1,723,876,000.00 | N/A |
| Revenue This Year | $22.56 | $1.70 |
| Revenue Next Year | $11.63 | $3.99 |
| P/E Ratio | $31.91 | ★ $10.11 |
| Revenue Growth | ★ 14.82 | N/A |
| 52 Week Low | $6.59 | $12.72 |
| 52 Week High | $15.41 | $19.09 |
| Indicator | GDOT | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 28.07 | 43.14 |
| Support Level | $10.20 | $13.28 |
| Resistance Level | $11.14 | $14.80 |
| Average True Range (ATR) | 0.33 | 0.29 |
| MACD | -0.10 | -0.02 |
| Stochastic Oscillator | 19.76 | 49.30 |
Green Dot Corp is a financial technology company that provides financial services for consumers in the United States without good banking options. It has three segments Consumer Services, Business to Business Services(B2B), and Money Movement Services. The company generates maximum revenue from B2B segment. Its B2B Services segment consists of revenues and expenses derived from (i) its partnerships with prominent consumer and technology companies that make banking products and services available to their consumers, partners and workforce through integration with its banking platform (the "Banking-as-a-Service", or "BaaS channel"), and (ii) a comprehensive payroll platform that it offers to corporate enterprises (the "Employer channel") to facilitate payments for today's workforce.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.